Home > Share Market > Stocks > Neuland laboratories > Financial Statements > NEULANDLAB Key Financial Ratios

Neuland laboratories Financial Statements

NEULANDLAB Ratio Analysis

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2019
Growth matrix (%)        
Revenue growth 1.51 22.80 14.40 26.40
Op profit growth (2.90) 44.10 74.60 15.70
EBIT growth (22) 65.40 107 9.55
Net profit growth (21) 397 (1.40) 36.30
Profitability ratios (%)        
OPM 15 15.70 13.40 8.75
EBIT margin 10.10 13.20 9.77 5.40
Net profit margin 6.71 8.61 2.13 2.47
RoCE 8.72 11.80 7.26 3.69
RoNW 1.96 2.69 0.58 0.65
RoA 1.45 1.94 0.39 0.42
Per share ratios ()        
EPS 49.50 62.50 12.60 12.70
Dividend per share 5 5 2 --
Cash EPS 11.50 31.90 (12) (7.30)
Book value per share 655 613 553 542
Valuation ratios        
P/E 20.80 33.40 22.50 52.90
P/CEPS 89.10 65.40 (24) (92)
P/B 1.57 3.41 0.51 1.24
EV/EBIDTA 10.60 17.40 5.49 17.10
Payout (%)        
Dividend payout -- -- -- --
Tax payout (22) (23) (69) (19)
Liquidity ratios        
Debtor days 86.70 79.40 84.70 98
Inventory days 98.40 91 98.60 101
Creditor days (64) (67) (69) (77)
Leverage ratios        
Interest coverage (7.10) (6.90) (3.50) (2.30)
Net debt / equity 0.26 0.21 0.31 0.28
Net debt / op. profit 1.54 1.11 2.13 3.32
Cost breakup ()        
Material costs (44) (47) (50) (55)
Employee costs (19) (16) (16) (17)
Other costs (21) (22) (21) (20)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000